VetDC wins big at BioWest

VetDC, a CSU spinoff, has won first prize in the Colorado Bioscience Association’s BioWest Venture Showcase.

The company works with pet owners and veterinarians at the CSU Veterinary Teaching Hospital and Animal Cancer Center to develop promising new veterinary therapies adopted from medicines that originally were developed for humans.

VetDC competed against four companies in Denver on Tuesday that pitched their echnologies and business plans to a panel of bioscience experts and venture capitalists in the BioWest Venture Showcase. Also competing Tuesday was KromaTID, another spinoff from CSU.

SPONSORED CONTENT

Business Cares: May 2024

As Mental Health Awareness Month unfolds in Colorado, it serves as a reminder of the collective responsibility to prioritize mental well-being.

VetDC took home the first prize and $7,500 in cash from the competition.

“We are thrilled and honored to be selected for this award, particularly given the high caliber of emerging bioscience companies participating in this year’s showcase,´ said Steven Roy, CEO of VetDC. “While transitioning medical advancements from animal testing to humans is quite common, innovations by human-focused biotechnology companies are rarely targeted for veterinary uses. Many of these therapies have great potential to benefit animals – and that’s where VetDC comes in.”

VetDC focuses mostly on cancer, which is considered to be the leading cause of death in adult pets today.